About

Board of Directors

Meet Our Board of Directors

Stephen L. Eck, MD, PhD

Stephen L. Eck, MD, PhD

President and CEO

Dr. Eck has over 15 years of leadership experience in the development of oncology drugs and related biomarkers. Prior to joining Aravive, he was Vice President of Oncology Medical Sciences at Astellas Pharma Global Development, Inc. (more…)

Amato Giaccia, PhD

Amato Giaccia, PhD

Chief Scientific Officer (Interim)

Dr. Giaccia is an internationally known cancer biologist and serial entrepreneur. In addition to his role as Chief Scientific Officer of Aravive Biologics, he is Professor of Radiation Oncology, Associate Chair for Research & Director of the Division of Radiation & Cancer Biology in the Department of Radiation Oncology at Stanford University School of Medicine. (more…)

Karen Liu, PhD

Karen Liu, PhD

Dr. Karen Liu is a founding partner of 3E Bioventures Capital, a healthcare focused venture capital firm. Prior to 3E Bioventures, Dr. Liu was a partner at Kaiwu Capital in charge of healthcare investment from 2011-2015 and before that, was Managing Director at CRCI Capital from 2007-2011, also in charge of healthcare investment. (more…)

Ray Tabibiazar, MD

Ray Tabibiazar, MD

Chairman

Dr. Tabibiazar brings more than 12 years of leadership experience in the healthcare industry, including key executive positions within the biopharmaceutical industry, as well as diagnostics, healthcare IT, and venture capital. In addition to his role at Aravive, he is also the Managing Director of 526 Ventures, a life sciences strategic consulting company working with both public and private biopharmaceutical firms. (more…)

Eric Zhang, CFA

Eric Zhang, CFA

Mr. Zhang is the Founding Managing Partner of Sky Kingdom Capital Ltd. (“SKC”), an early stage investor in the healthcare, technology and media sectors in the U.S. and Greater China region. SKC is led by former senior investment banking and industry professionals in Hong Kong, and manages capital for high net worth, successful entrepreneurs in Greater China. (more…)